BiotechTube
Home/Nxera Pharma/Malcolm Weir, Ph.D.
MW

Malcolm Weir, Ph.D.

Executive VP, R&D and Chief R&D Officer

Nxera Pharma

Therapeutic Areas

NeuroscienceImmuno-oncology

Nxera Pharma Pipeline

DrugIndicationPhase
HTL0018318Alzheimer's Disease Psychosis, SchizophreniaPhase 2
HTL0014242SchizophreniaPhase 1
HTL0039732Oncology (Immuno-oncology)Phase 1
HTL0046509Ulcerative ColitisPreclinical
HTL0016878Chronic Kidney Disease, Metabolic DisordersPreclinical

Leadership Team at Nxera Pharma

CC
Chris Cargill
President & CEO
ST
Shinichi Tamura
Chairman & Representative Director
MC
Miles Congreve, FRS
Chief Scientific Officer & Sosei Heptares COO
RG
Robert Gould, Ph.D.
Non-Executive Director
View full Nxera Pharma profile